Elan CEO to step down in two years
Elan CEO Kelly Martin is to leave the pharmaceutical giant in two year’s time, it was announced today.
Mr Martin’s change from an open-ended employment contract to a fixed term agreement will see him remain in his current roles as CEO and director of the company through May 1, 2012.